Literature DB >> 34981435

Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: a systematic review.

Ana Patrícia Bastos Ferreira1,2, Ana Dolores Firmino Santos do Nascimento1,3, Pedro Augusto Sampaio Rocha-Filho4,5.   

Abstract

To verify brain and spinal changes using magnetic resonance imaging in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis. This was a systematic review. The descriptors used were tropical spastic paraparesis and magnetic resonance image. The keyword HTLV-1-associated myelopathy was also used. Twenty-three articles were included: 16 detected brain changes and 18 detected spinal changes. White matter lesions were the most frequent finding in the brain. Brain injuries were most frequently identified in the periventricular region, in the subcortical region, in the centrum semiovale, in the brain stem, and corpus callosum. Atrophy was the most frequent finding of the spinal cord, affecting the thoracic and cervical regions, and was associated with a longer evolution of myelopathy. White matter lesions in these regions were also observed. Cortical white matter lesions and thoracic spinal cord atrophy were the most frequently reported changes in patients with HTLV-1-associated myelopathy.
© 2021. Journal of NeuroVirology, Inc.

Entities:  

Keywords:  Brain; Human T-lymphotropic virus 1; Magnetic resonance imaging; Spinal cord; Tropical spastic paraparesis

Mesh:

Year:  2022        PMID: 34981435     DOI: 10.1007/s13365-021-01043-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  32 in total

1.  HTLV-I-associated myelopathy/tropical spastic paraparesis: semiautomatic quantification of spinal cord atrophy from 3-dimensional MR images.

Authors:  Iordanis E Evangelou; Raya Massoud; Steven Jacobson
Journal:  J Neuroimaging       Date:  2012-02-03       Impact factor: 2.486

2.  Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).

Authors:  Carlos M De Castro-Costa; Abelardo Q C Araújo; Márcio M Barreto; Osvaldo M Takayanagui; Marzia P Sohler; Eduardo L M da Silva; Sônia M B de Paula; Ricardo Ishak; João G R Ribas; Luis C Rovirosa; Herwig Carton; Eduardo Gotuzzo; William W Hall; Silvia Montano; Edward L Murphy; Joel Oger; Carlos Remondegui; Graham P Taylor
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

3.  Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status.

Authors:  M R P Gascón; J Casseb; J Smid; J E Vidal; L A M Fonseca; A Paiva; M J Haziot; A C Penalva de Oliveira
Journal:  J Neurol Sci       Date:  2017-04-13       Impact factor: 3.181

Review 4.  [Infection and disease caused by the human T cell lymphotropic viruses type I and II in Brazil].

Authors:  Anna Bárbara F Carneiro-Proietti; João Gabriel Ramos Ribas; Bernadette C Catalan-Soares; Marina L Martins; Gustavo E A Brito-Melo; Olindo A Martins-Filho; Sônia R Pinheiro; Abelardo de Queiroz-Campos Araújo; Bernardo Galvão-Castro; Maria S Pombo de Oliveira; Antônio Carlos Guedes; Fernando Augusto Proietti
Journal:  Rev Soc Bras Med Trop       Date:  2002 Sep-Oct       Impact factor: 1.581

5.  Multiple spotty lesions of the spinal cord in a Chinese patient with human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Hongzhi Gao; Xiang Ye; Ruowei Cai; Qiping Xu; Liping Liang; Shuji Izumo; Hui Qin Xing; Ryuji Kubota
Journal:  Int J Infect Dis       Date:  2017-12-29       Impact factor: 3.623

6.  Human T-cell lymphotropic virus type 1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis.

Authors:  A G Douen; C E Pringle; A Guberman
Journal:  Arch Neurol       Date:  1997-07

7.  Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis.

Authors:  Francesca Bagnato; John A Butman; Carlos A Mora; Shiva Gupta; Yoshima Yamano; Talin A Tasciyan; Jeffrey M Solomon; Waldyr J Santos; Roger D Stone; Henry F McFarland; Steven Jacobson
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

8.  [Botulinum toxin A: experience in the treatment of 115 patients].

Authors:  L A Andrade; V Borges; H B Ferraz; S M Azevedo-Silva
Journal:  Arq Neuropsiquiatr       Date:  1997-09       Impact factor: 1.420

9.  Cognitive event-related potentials and brain magnetic resonance imaging in HTLV-1 associated myelopathy (HAM).

Authors:  T Fukushima; T Ikeda; E Uyama; M Uchino; H Okabe; M Ando
Journal:  J Neurol Sci       Date:  1994-10       Impact factor: 3.181

10.  Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies.

Authors:  F Alcindor; R Valderrama; M Canavaggio; H Lee; A Katz; C Montesinos; R E Madrid; R R Merino; P A Pipia
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.